Search Results for: asthma

Item 6b – Inhaler review (COPD and asthma pathways) The FSG welcomed Professor Dave Singh to the meeting for the discussion on asthma and COPD pathways. Action: MM to incorporate inhaler choices into the COPD and asthma pathways and prepare for GM-wide consultation.

SABA inhalers for asthma will have a maximum number of issues of 4 per year to help identify overuse/deterioration of underlying condition. over ordering of salbutamol inhalers for an asthmatic patient. antipsychotics, asthma preventer inhalers.

Asthma Management Plan – Inhaler Guide, GMMMG, 2022 Lists inhalers recommended by GM formulary. How to use your inhaler, Asthma + Lung UK website Videos on appropriate inhaler technics including the following devices: pMDI, accuhaler, Spiromax, NEXThaler, Ellipta, Respimat, and tidal breathing.

Clinical Knowledge Summaries, Asthma, last revised April 2018, available from https://cks.nice.org.uk/asthma 19. UKMi5, CKS Asthma18 Chapter 3 Patient familiarity with one brand is important; 3.1-3.2 All inhalers instructions for use vary between preparations and patient training is required [8].

Item 6b – Inhaler review (COPD and asthma pathways) The FSG considered draft COPD and asthma pathways at the October meeting.

Other monoclonal antibodies for asthma are on formulary as RED drugs in chapter 3.

Action: None required from MGSG, IBD pathway progress to continue 3.3 GM Asthma management plan This item was discussed ahead of item 1.3 to enable Dr Raja (MHCC Clinical Lead for respiratory medicine, and GM&EC SCN GP Clinical Lead for respiratory medicine, who was in attendance, to return to clinical work.

4.4) Asthma pathway The final version of the GMMMG asthma pathway was presented to and approved by the group. ACTION: GM to send Asthma Pathway to next GMMMG meeting for ratification.

The guideline has been developed and approved by the GM Asthma working group and is submitted for approval to open for consultation across GM.